Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Jynneos
Pharma
NIH study shows mpox shot elicits immune response in teens
Interim results of an NIH trial of Bavarian Nordic's Jynneos indicate that it is safe and elicits an immune response in teens.
Kevin Dunleavy
Oct 17, 2024 11:17am
UNICEF taps Bavarian Nordic for 1M mpox vaccines
Sep 27, 2024 11:27am
Bavarian Nordic eyes partnerships to produce more mpox vaccines
Sep 12, 2024 12:15pm
Bavarian Nordic inks another supply deal for smallpox/mpox shot
Aug 22, 2024 2:13pm
Bavarian Nordic poised to deliver 10M mpox vaccines to Africa
Aug 19, 2024 11:03am
Bavarian Nordic locks up $157M Jynneos supply pact with US
Aug 8, 2024 9:09am
